Big Health Raises $24 Million in Digital Mental Health Investment
Big Health announced Thursday it secured $23.7 million from notable investors, marking renewed confidence in the digital therapeutics sector. The funding represents a significant vote of confidence for app-based medical treatments as the industry seeks recovery from recent setbacks.
Digital Therapeutics Market Shows Recovery Signs
Founded in 2010, Big Health develops cognitive behavioral therapy applications treating anxiety and insomnia through evidence-based digital interventions. The company represents the original vanguard of digital therapeutics startups that promised software-based medical treatments would revolutionize healthcare access while generating substantial returns.
The digital therapeutics sector experienced turbulence following high-profile failures. Pear Therapeutics collapsed in 2023 and filed for bankruptcy, while Akili Interactive failed to meet expectations for its ADHD-treating video game. These setbacks demonstrated that convincing insurers, clinicians, and patients to adopt entirely new treatment modalities proved more challenging than anticipated.
Medicare Billing Codes Drive Renewed Momentum
Yael Berman, who assumed the CEO role at Big Health in 2024, attributes the new investment to recent progress with payers and health system customers. Medicare billing codes for digital mental health treatments have created tangible reimbursement pathways, addressing one of the sector’s most significant barriers.
The availability of proper billing codes enables healthcare providers to receive compensation for prescribing digital therapeutics, fundamentally changing the adoption equation. This infrastructure development represents the missing link between clinical validation and widespread implementation.
Cognitive Behavioral Therapy Apps Address Mental Health Crisis
Big Health’s flagship products deliver cognitive behavioral therapy through mobile applications, targeting the growing mental health treatment gap. Traditional CBT requires trained therapists and regular in-person sessions, creating access barriers for millions of patients. Digital delivery mechanisms expand treatment availability while maintaining therapeutic effectiveness.
The company’s insomnia and anxiety applications utilize evidence-based protocols adapted for smartphone delivery. Users receive personalized treatment plans, progress tracking, and therapeutic interventions without scheduling traditional appointments. This approach particularly benefits underserved populations lacking access to mental health specialists.
Healthcare System Integration Drives Adoption
The recent funding will accelerate Big Health’s integration efforts with major healthcare systems. Provider adoption requires demonstrating clinical outcomes, ensuring interoperability with electronic health records, and establishing clear reimbursement mechanisms. The Medicare billing codes provide the financial framework supporting these integration initiatives.
Healthcare systems increasingly recognize digital therapeutics as complementary tools addressing capacity constraints in mental health services. By offering evidence-based digital options, providers can serve more patients while reserving in-person therapy for complex cases requiring direct human interaction.
Investment Signals Industry Confidence Recovery
The $23.7 million investment from established healthcare investors demonstrates renewed sector confidence despite previous challenges. Investors appear convinced that infrastructure improvements, including Medicare billing codes and provider education, have created conditions for sustainable digital therapeutics growth.
This funding round suggests the market has learned valuable lessons from earlier failures. Successful digital therapeutics companies must demonstrate clear clinical evidence, establish reimbursement pathways, and integrate seamlessly into existing healthcare workflows rather than attempting to create entirely parallel treatment systems.
Future Outlook for Digital Mental Health Solutions
Big Health’s funding success may indicate broader industry recovery as digital therapeutics mature from experimental treatments to established care options. The combination of clinical validation, reimbursement infrastructure, and proven business models creates more favorable conditions than existed during earlier market enthusiasm.
The mental health crisis affecting millions of Americans provides substantial market opportunity for effective digital solutions. As healthcare systems struggle with therapist shortages and growing demand, validated digital therapeutics offer scalable alternatives that can expand access while maintaining treatment quality.
